查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1799200

全球智慧植入帮浦市场

Smart Implantable Pumps
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 173 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球智慧植入帮浦市场规模将达到 36 亿美元

全球智慧植入帮浦市场规模预计在2024年为27亿美元，到2030年将达到36亿美元，2024年至2030年的复合年增长率为5.3%。智慧灌溉帮浦是本报告分析的细分市场之一，预计其复合年增长率为4.2%，到分析期结束时规模将达到22亿美元。智慧微泵细分市场在分析期间的复合年增长率预计为7.2%。

美国市场规模估计为 6.976 亿美元，中国市场预计复合年增长率为 5.3%

美国智慧植入帮浦市场规模预计在2024年达到6.976亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到5.859亿美元，在分析期间（2024-2030年）的复合年增长率为5.3%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为4.8%和4.6%。在欧洲，德国的复合年增长率预计为4.4%。

全球智慧植入帮浦市场—主要趋势与驱动因素摘要

智慧植入帮浦将如何改变慢性病治疗？

智慧植入式帮浦透过提供可程式设计、精准、持续的输注功能，彻底改变了药物和治疗剂向人体的传递方式。与体外或手动输送方式不同，这些小型生物相容性装置可透过手术植入皮下或腔内，确保以最少的患者介入实现有针对性的长期治疗。它们对于治疗疼痛、痉挛、糖尿病、癌症和心血管疾病等慢性疾病至关重要，因为持续的剂量和对生理回馈的反应至关重要。

智慧植入式帮浦与传统系统的差异在于其整合了感测器、微处理器和无线遥测技术，因此可以进行即时调整、资料登录和临床医生监测。患者不再需要遵守严格的给药方案，也不再需要忍受传统药物治疗方案的剂量波动。相反，这些系统可以根据生物讯号调整剂量，从而改善疗效并减少副作用。它们还消除了频繁就诊的需要，使其成为远端医疗和个人化医疗的基石。

下一代植入式输送系统背后有何技术？

现代智慧泵融合了电子机械系统 (MEMS)、无线通讯、低功耗设计和生物相容性材料。 MEMS 技术在不影响功能性的情况下实现了微型化，使帮浦能够透过微创手术安全地植入和补充。一些帮浦配备了压力和流量感测器，可以监测输液精度、检测堵塞情况并回应患者的生理变化。

无线远端检测可透过手持式程式设计器或支援蓝牙的智慧型手机，在装置与外部读取器或临床医生介面之间实现双向通讯。临床医生可以远端监控用药历史、电池寿命和设备功能，甚至可以即时调整剂量。可充电电池、感应式充电技术和能源采集机制可延长设备寿命，并减少手术介入的需求。与云端基础健康平台集成，可实现长期数据跟踪，为临床决策提供支援。

智慧植入帮浦在哪些方面有最大的临床影响？

这些设备在肿瘤学领域带来了改变生命的益处，持续输注化疗药物可以更好地针对肿瘤，同时降低全身毒性。在疼痛管理方面，智慧型帮浦鞘内给药是阿片类药物的强效替代方案，可最大限度地减少对药物的依赖，并改善顽固性疼痛患者的生活品质。对于痉挛性疼痛，例如多发性硬化症和脑性麻痹，智慧Baclofen帮浦可实现精准的靶向神经调节。

虽然体外胰岛素帮浦仍是糖尿病治疗的主流，但植入式胰岛素帮浦正逐渐兴起，用于长期血糖管理，尤其是与连续血糖监测仪 (CGM) 结合使用。心臟病学是另一个蓬勃发展的领域，目前正在开发用于控制输送抗凝血剂、抗高血压药物和抗心律不整药物的智慧帮浦。此外，人们正在探索透过植入式输注系统进行颅内标靶给药，以治疗帕金森氏症和阿兹海默症神经退化性疾病。

智慧植入帮浦市场的成长受到多种因素的推动…

由于全球慢性病和文明病的增多，需要持续治疗和高度标靶治疗，市场正在迅速扩张。微型化、电源管理、遥测和药物储库材料的技术进步正在提高设备的使用寿命、安全性和反应速度。对远端患者监护、医院-居家照护模式以及个人化治疗通讯协定的需求日益增长，也提升了智慧自主给药系统的吸引力。

此外，优惠的报销框架、对数位疗法的监管支持以及临床医生对植入式设备的日益熟悉，正在降低其应用门槛。医疗科技公司、数位健康平台和製药公司之间的合作也推动了基于帮浦的给药模式的创新。随着医疗保健系统优先考虑患者依从性、基于疗效的护理和具有成本效益的慢性病管理，智慧植入式帮浦有望成为下一代疗法的基础要素。

部分

帮浦类型（智慧灌注帮浦、智慧微型帮浦）、应用（疼痛应用、痉挛应用、心血管应用、其他应用）、最终用途（医院最终用途、门诊手术中心最终用途、其他最终用途）

受访公司范例

  • Abbott Laboratories
  • Abiomed（Johnson & Johnson）
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics, Inc.
  • Debiotech SA
  • D. Medical Industries Ltd.
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Insulet Corporation
  • Intarcia Therapeutics, Inc.
  • Johnson & Johnson（other implants）
  • Medtronic plc
  • MPS Microsystems
  • Q-Core Medical Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • Tandem Diabetes Care, Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 比赛

简介目录
Product Code: MCP39353

Global Smart Implantable Pumps Market to Reach US$3.6 Billion by 2030

The global market for Smart Implantable Pumps estimated at US$2.7 Billion in the year 2024, is expected to reach US$3.6 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Smart Perfusion Pumps, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.2 Billion by the end of the analysis period. Growth in the Smart Micro Pumps segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$697.6 Million While China is Forecast to Grow at 5.3% CAGR

The Smart Implantable Pumps market in the U.S. is estimated at US$697.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$585.9 Million by the year 2030 trailing a CAGR of 5.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Smart Implantable Pumps Market - Key Trends & Drivers Summarized

How Are Smart Implantable Pumps Transforming Chronic Disease Therapy?

Smart implantable pumps are revolutionizing the delivery of medications and therapeutic agents within the human body by providing programmable, precise, and continuous infusion capabilities. Unlike external or manual delivery methods, these miniature, biocompatible devices are surgically placed under the skin or within body cavities to ensure targeted, long-term treatment with minimal patient intervention. They are critical for managing chronic conditions such as pain, spasticity, diabetes, cancer, and cardiovascular diseases, where consistent dosing and responsiveness to physiological feedback are essential.

What differentiates smart implantable pumps from legacy systems is their integration with sensors, microprocessors, and wireless telemetry, enabling real-time adjustments, data logging, and clinician oversight. Patients no longer need to adhere to strict dosing schedules or tolerate the peaks and troughs of conventional drug regimens. Instead, these systems can titrate doses based on biological signals, improving therapeutic outcomes and reducing side effects. They also eliminate the need for frequent hospital visits, making them a linchpin of remote and personalized healthcare.

What Technologies Are Powering Next-Generation Implantable Delivery Systems?

The modern smart pump is a convergence of microelectromechanical systems (MEMS), wireless communication, low-power electronics, and biocompatible materials. MEMS technology enables miniaturization without compromising functionality, allowing pumps to be safely implanted and refilled through minimally invasive procedures. Some pumps are equipped with pressure and flow sensors that monitor infusion accuracy, detect occlusions, or adjust for changes in patient physiology.

Wireless telemetry allows two-way communication between the device and external readers or clinician interfaces, often via handheld programmers or Bluetooth-enabled smartphones. Physicians can remotely monitor dosage history, battery life, and device function-and even make dosing adjustments in real time. Rechargeable batteries, inductive charging technologies, and energy harvesting mechanisms are enabling longer device lifespans and fewer surgical interventions. Integration with cloud-based health platforms allows longitudinal data tracking for clinical decision support.

Where Are Smart Implantable Pumps Making the Most Clinical Impact?

These devices are delivering life-changing benefits in oncology, where continuous infusion of chemotherapeutics can increase tumor targeting while reducing systemic toxicity. In pain management, intrathecal drug delivery via smart pumps offers a powerful alternative to opioids, minimizing dependence and improving quality of life for patients with intractable pain. For spasticity in conditions like multiple sclerosis and cerebral palsy, smart baclofen pumps allow precise, targeted neuromodulation.

In diabetes care, while external insulin pumps dominate, implantable versions are gaining ground for long-term glucose management, especially when coupled with continuous glucose monitors (CGMs). Cardiology is another growing frontier, with smart pumps under development for the controlled delivery of anticoagulants, antihypertensives, and anti-arrhythmic agents. Additionally, investigational applications in neurodegenerative disorders, such as Parkinson’s and Alzheimer’s disease, involve targeted intracranial delivery of therapeutics via implantable infusion systems.

The Growth in the Smart Implantable Pumps Market Is Driven by Several Factors…

The market is expanding rapidly due to rising global prevalence of chronic and lifestyle-related diseases requiring continuous or highly targeted therapy. Technological advancements in miniaturization, power management, telemetry, and drug reservoir materials are enhancing device longevity, safety, and responsiveness. Increasing demand for remote patient monitoring, hospital-at-home care models, and personalized treatment protocols is reinforcing the appeal of smart, autonomous delivery systems.

Furthermore, favorable reimbursement frameworks, regulatory support for digital therapeutics, and growing clinician familiarity with implantable devices are reducing adoption barriers. Collaborations between medtech firms, digital health platforms, and pharmaceutical companies are also fostering innovation in pump-enabled drug delivery models. As healthcare systems prioritize patient adherence, outcome-based care, and cost-effective chronic disease management, smart implantable pumps are poised to become a foundational element of next-generation therapeutics.

SCOPE OF STUDY:

The report analyzes the Smart Implantable Pumps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Pump Type (Smart Perfusion Pumps, Smart Micro Pumps); Application (Pain Application, Spasticity Application, Cardiovascular Application, Other Applications); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Abbott Laboratories
  • Abiomed (Johnson & Johnson)
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • Boston Scientific Corporation
  • Cognos Therapeutics, Inc.
  • Debiotech SA
  • D. Medical Industries Ltd.
  • Flowonix Medical Inc.
  • Fresenius Kabi AG
  • Insulet Corporation
  • Intarcia Therapeutics, Inc.
  • Johnson & Johnson (other implants)
  • Medtronic plc
  • MPS Microsystems
  • Q-Core Medical Ltd.
  • Smiths Medical
  • Terumo Corporation
  • Tricumed Medizintechnik GmbH
  • Tandem Diabetes Care, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Smart Implantable Pumps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rise in Chronic Disease Management Needs Propels Demand for Implantable Drug Delivery Devices
    • Miniaturization and Biocompatibility Advancements Drive Adoption of Smart Implantable Pumps
    • Integration with Remote Monitoring Platforms Strengthens Case for Connected Drug Delivery Systems
    • Increased Use of Closed-Loop Systems in Diabetes Management Expands Addressable Market
    • Clinical Shift Toward Targeted and Personalized Therapies Spurs Smart Pump Innovation
    • Surge in Demand for Pain Management Solutions Drives Interest in Programmable Intrathecal Pumps
    • Expansion of Wearables and Implantables Ecosystems Supports Smart Pump Interoperability
    • Real-Time Data Feedback Loops Enable Adaptive Dosing and Improved Patient Outcomes
    • Improved Battery Life and Wireless Charging Capabilities Enhance Patient Comfort and Compliance
    • Remote Software Updates and Physician Control Platforms Drive Clinical Utility
    • Growth of Home-Based Infusion Therapy Creates Demand for Safe, Long-Term Implantable Delivery
    • Regulatory Support for Digital Therapeutics Encourages Smart Pump Innovation in Niche Therapies
    • Collaborations Between MedTech and Biopharma Firms Fuel Innovation in Combination Delivery Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Smart Implantable Pumps Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Smart Perfusion Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Smart Perfusion Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Smart Micro Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Smart Micro Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pain Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Pain Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spasticity Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Spasticity Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiovascular Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiovascular Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 22: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 23: USA 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • JAPAN
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • CHINA
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 40: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: China 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • EUROPE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 47: Europe 6-Year Perspective for Smart Implantable Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • FRANCE
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 54: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: France 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • GERMANY
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Germany 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ITALY
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Italy 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • UNITED KINGDOM
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 72: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: UK 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Smart Implantable Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Pump Type - Smart Perfusion Pumps and Smart Micro Pumps - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of World 6-Year Perspective for Smart Implantable Pumps by Pump Type - Percentage Breakdown of Value Sales for Smart Perfusion Pumps and Smart Micro Pumps for the Years 2025 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by Application - Pain Application, Spasticity Application, Cardiovascular Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Smart Implantable Pumps by Application - Percentage Breakdown of Value Sales for Pain Application, Spasticity Application, Cardiovascular Application and Other Applications for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Smart Implantable Pumps by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Smart Implantable Pumps by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Other End-Uses for the Years 2025 & 2030

IV. COMPETITION